Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for Stephen E. O'Neil
3.09
+0.18 (6.19%)
Feb 21 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 2.93 - 3.10
52 week 2.16 - 9.65
Open 3.09
Vol / Avg. 0.00/36,621.00
Mkt cap 27.72M
P/E     -
Div/yield     -
EPS -3.08
Shares 8.91M
Beta 1.54
Inst. own 55%
Mar 13, 2017
Q4 2016 Alphatec Holdings Inc Earnings Release (Estimated) - 4:00PM EDT - Add to calendar
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '16) 2015
Net profit margin -37.67% -96.44%
Operating margin -52.51% -93.07%
EBITD margin - 7.03%
Return on average assets -34.72% -72.74%
Return on average equity - -317.99%
Employees 430 -
CDP Score - -

Address

5818 El Camino Real
CARLSBAD, CA 92008
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries, designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its products include Cervical and Cervico-Thoracic Products, which include Trestle Luxe Anterior Cervical Plate System and Pegasus Anchored Cervical Interbody; Thoracolumbar Fixation Products, which include Arsenal Degenerative System and OsseoScrew Spinal Fixation System; Spinal Spacers, which include Battalion Universal Spacer System and Alphatec Solus Locking ALIF Spinal Spacer; minimally invasive surgery Products, which include Illico Minimally Invasive Surgery System and BridgePoint Spinous Process Fixation System, and Biologics, which include Neocore Osteoconductive Matrix.

Officers and directors

Mortimer Berkowitz III Chairman of the Board
Age: 62
Bio & Compensation  - Reuters
Michael Joseph Plunkett President, Chief Operating Officer
Age: 59
Bio & Compensation  - Reuters
Terry M. Rich Chief Executive Officer, Director
Age: 48
Bio & Compensation  - Reuters
Dennis T. Nelson Interim Principal Financial and Accounting Officer
Age: 43
Bio & Compensation  - Reuters
Jon Allen Executive Vice President - Commercial Operations
Bio & Compensation  - Reuters
Craig E. Hunsaker Executive Vice President - People and Culture
Age: 50
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Corporate Secretary
Age: 44
Bio & Compensation  - Reuters
Kristin Machacek Leary Senior Vice President - Global Human Resources
Age: 47
Bio & Compensation  - Reuters
Amy Ables Ph.D. Vice President - Corporate Education & Performance
Bio & Compensation  - Reuters
Donald A. Williams Lead Independent Director
Age: 57
Bio & Compensation  - Reuters